rs2273650

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_020529.3(NFKBIA):​c.*421G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0257 in 291,100 control chromosomes in the GnomAD database, including 735 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.017 ( 223 hom., cov: 32)
Exomes 𝑓: 0.035 ( 512 hom. )

Consequence

NFKBIA
NM_020529.3 3_prime_UTR

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 2.64

Publications

16 publications found
Variant links:
Genes affected
NFKBIA (HGNC:7797): (NFKB inhibitor alpha) This gene encodes a member of the NF-kappa-B inhibitor family, which contain multiple ankrin repeat domains. The encoded protein interacts with REL dimers to inhibit NF-kappa-B/REL complexes which are involved in inflammatory responses. The encoded protein moves between the cytoplasm and the nucleus via a nuclear localization signal and CRM1-mediated nuclear export. Mutations in this gene have been found in ectodermal dysplasia anhidrotic with T-cell immunodeficiency autosomal dominant disease. [provided by RefSeq, Aug 2011]
NFKBIA Gene-Disease associations (from GenCC):
  • ectodermal dysplasia and immunodeficiency 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
  • ectodermal dysplasia and immune deficiency
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_020529.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.42).
BP6
Variant 14-35401592-C-T is Benign according to our data. Variant chr14-35401592-C-T is described in ClinVar as Benign. ClinVar VariationId is 313099.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.251 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020529.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NFKBIA
NM_020529.3
MANE Select
c.*421G>A
3_prime_UTR
Exon 6 of 6NP_065390.1P25963

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NFKBIA
ENST00000216797.10
TSL:1 MANE Select
c.*421G>A
3_prime_UTR
Exon 6 of 6ENSP00000216797.6P25963
NFKBIA
ENST00000860149.1
c.*421G>A
3_prime_UTR
Exon 6 of 6ENSP00000530208.1
NFKBIA
ENST00000697961.1
c.*790G>A
3_prime_UTR
Exon 5 of 5ENSP00000513487.1A0A8V8TLC3

Frequencies

GnomAD3 genomes
AF:
0.0171
AC:
2598
AN:
152186
Hom.:
222
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00193
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0315
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.262
Gnomad SAS
AF:
0.0715
Gnomad FIN
AF:
0.0181
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.00137
Gnomad OTH
AF:
0.0167
GnomAD4 exome
AF:
0.0352
AC:
4890
AN:
138796
Hom.:
512
Cov.:
0
AF XY:
0.0365
AC XY:
2542
AN XY:
69592
show subpopulations
African (AFR)
AF:
0.00194
AC:
9
AN:
4646
American (AMR)
AF:
0.0445
AC:
268
AN:
6022
Ashkenazi Jewish (ASJ)
AF:
0.00116
AC:
7
AN:
6048
East Asian (EAS)
AF:
0.259
AC:
3423
AN:
13226
South Asian (SAS)
AF:
0.0738
AC:
854
AN:
11568
European-Finnish (FIN)
AF:
0.0122
AC:
30
AN:
2454
Middle Eastern (MID)
AF:
0.0114
AC:
7
AN:
612
European-Non Finnish (NFE)
AF:
0.00134
AC:
114
AN:
84856
Other (OTH)
AF:
0.0190
AC:
178
AN:
9364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
187
375
562
750
937
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0170
AC:
2594
AN:
152304
Hom.:
223
Cov.:
32
AF XY:
0.0209
AC XY:
1558
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.00192
AC:
80
AN:
41572
American (AMR)
AF:
0.0314
AC:
480
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
6
AN:
3472
East Asian (EAS)
AF:
0.262
AC:
1358
AN:
5180
South Asian (SAS)
AF:
0.0714
AC:
345
AN:
4834
European-Finnish (FIN)
AF:
0.0181
AC:
192
AN:
10608
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.00137
AC:
93
AN:
68028
Other (OTH)
AF:
0.0170
AC:
36
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
115
230
346
461
576
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00815
Hom.:
27
Bravo
AF:
0.0181
Asia WGS
AF:
0.186
AC:
645
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Ectodermal dysplasia and immunodeficiency 2 (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.42
CADD
Benign
20
DANN
Benign
0.76
PhyloP100
2.6
RBP_binding_hub_radar
0.92
RBP_regulation_power_radar
3.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2273650;
hg19: chr14-35870798;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.